Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...

Texas-based telepsychiatry practice adopts structured, clinician-reviewed assessment model to enhance diagnostic rigor ...

Led by YSPH and partners at CIDEIM at Icesi University, the research team conducted the study in Cali, Colombia.

A hospital and nurse practitioner are sued after discharging a patient with medication for a panic attack, without having performed crucial tests and following protocol.

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...

Sunrise Group, a pioneer in medical device innovation and sleep care, today announced results from the SUNSAS clinical study, now published in The Lancet Regional Health – Europe, a leading ...

Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue ANN ARBOR, MI / ACCESS ...

A simple five-minute test addressing major endometriosis diagnostic delays and treatment, has been developed by University of ...

The new guidance includes recommendations for MRI and transvaginal ultrasonography in the evaluation of suspected endometriosis.

The World Health Organization (WHO) is issuing, for the first time, recommendations on new near-point-of-care (NPOC) molecular tests for the diagnosis of tuberculosis (TB); easy-to-collect ...